PHOTRONICS INC (PLAB)

US7194051022 - Common Stock

29.38  +0.36 (+1.24%)

After market: 29.74 +0.36 (+1.23%)

Fundamental Rating

7

Taking everything into account, PLAB scores 7 out of 10 in our fundamental rating. PLAB was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. PLAB has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PLAB is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, PLAB could be worth investigating further for value and quality investing!.



8

1. Profitability

1.1 Basic Checks

In the past year PLAB was profitable.
PLAB had a positive operating cash flow in the past year.
Each year in the past 5 years PLAB has been profitable.
In the past 5 years PLAB always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 8.70%, PLAB is in the better half of the industry, outperforming 71.70% of the companies in the same industry.
PLAB has a Return On Equity of 13.46%. This is in the better half of the industry: PLAB outperforms 72.64% of its industry peers.
PLAB's Return On Invested Capital of 13.56% is amongst the best of the industry. PLAB outperforms 83.02% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PLAB is in line with the industry average of 10.53%.
The 3 year average ROIC (11.47%) for PLAB is below the current ROIC(13.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.7%
ROE 13.46%
ROIC 13.56%
ROA(3y)7.18%
ROA(5y)5.41%
ROE(3y)11.29%
ROE(5y)8.39%
ROIC(3y)11.47%
ROIC(5y)8.59%

1.3 Margins

PLAB's Profit Margin of 15.34% is fine compared to the rest of the industry. PLAB outperforms 71.70% of its industry peers.
PLAB's Profit Margin has improved in the last couple of years.
The Operating Margin of PLAB (28.37%) is better than 85.85% of its industry peers.
PLAB's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 37.82%, PLAB is not doing good in the industry: 66.04% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PLAB has grown nicely.
Industry RankSector Rank
OM 28.37%
PM (TTM) 15.34%
GM 37.82%
OM growth 3Y39.36%
OM growth 5Y18.28%
PM growth 3Y36.39%
PM growth 5Y12.33%
GM growth 3Y19.48%
GM growth 5Y8.93%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PLAB is still creating some value.
PLAB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PLAB has less shares outstanding
Compared to 1 year ago, PLAB has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 4.06 indicates that PLAB is not in any danger for bankruptcy at the moment.
The Altman-Z score of PLAB (4.06) is comparable to the rest of the industry.
The Debt to FCF ratio of PLAB is 0.14, which is an excellent value as it means it would take PLAB, only 0.14 years of fcf income to pay off all of its debts.
PLAB has a Debt to FCF ratio of 0.14. This is amongst the best in the industry. PLAB outperforms 83.96% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, PLAB is doing good in the industry, outperforming 70.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Altman-Z 4.06
ROIC/WACC1.09
WACC12.48%

2.3 Liquidity

PLAB has a Current Ratio of 4.36. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PLAB (4.36) is better than 71.70% of its industry peers.
A Quick Ratio of 4.09 indicates that PLAB has no problem at all paying its short term obligations.
The Quick ratio of PLAB (4.09) is better than 76.42% of its industry peers.
Industry RankSector Rank
Current Ratio 4.36
Quick Ratio 4.09

5

3. Growth

3.1 Past

PLAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.86%, which is quite impressive.
PLAB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 28.16% yearly.
Looking at the last year, PLAB shows a small growth in Revenue. The Revenue has grown by 6.09% in the last year.
The Revenue has been growing by 10.75% on average over the past years. This is quite good.
EPS 1Y (TTM)21.86%
EPS 3Y56.72%
EPS 5Y28.16%
EPS growth Q2Q82.61%
Revenue 1Y (TTM)6.09%
Revenue growth 3Y13.53%
Revenue growth 5Y10.75%
Revenue growth Q2Q2.48%

3.2 Future

Based on estimates for the next years, PLAB will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.61% on average per year.
Based on estimates for the next years, PLAB will show a small growth in Revenue. The Revenue will grow by 6.08% on average per year.
EPS Next Y7.3%
EPS Next 2Y9.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.92%
Revenue Next 2Y6.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.17, the valuation of PLAB can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 91.51% of the companies listed in the same industry.
PLAB is valuated cheaply when we compare the Price/Earnings ratio to 28.05, which is the current average of the S&P500 Index.
PLAB is valuated reasonably with a Price/Forward Earnings ratio of 11.99.
92.45% of the companies in the same industry are more expensive than PLAB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.30. PLAB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.17
Fwd PE 11.99

4.2 Price Multiples

PLAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PLAB is cheaper than 98.11% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 95.28% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.8
EV/EBITDA 3.94

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PLAB has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.8
PEG (5Y)0.47
EPS Next 2Y9.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (5/8/2024, 7:12:43 PM)

After market: 29.74 +0.36 (+1.23%)

29.38

+0.36 (+1.24%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.86B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 13.17
Fwd PE 11.99
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.8
PEG (5Y)0.47
Profitability
Industry RankSector Rank
ROA 8.7%
ROE 13.46%
ROCE
ROIC
ROICexc
ROICexgc
OM 28.37%
PM (TTM) 15.34%
GM 37.82%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.36
Quick Ratio 4.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)21.86%
EPS 3Y56.72%
EPS 5Y
EPS growth Q2Q
EPS Next Y7.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.09%
Revenue growth 3Y13.53%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y